Bederocin
Bederocin (REP8839) is a Methionyl-tRNA synthetase inhibitor. Bederocin can be used in research of bacterial infection, including S. aureus and MRSA[1].
Product Specifications
CAS Number
[757942-43-1]
Product Name Alternative
REP8839
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/bederocin.html
Purity
99.6
Solubility
10 mM in DMSO
Smiles
O=C1C=C(NCCCNCC2=C(C)C(Br)=C(C(F)=C)S2)NC3=C1C=CC=C3
Molecular Formula
C20H21BrFN3OS
Molecular Weight
450.37
Precautions
H302, H315, H319, H335
References & Citations
[1]Ochsner UA, et al. Mode of action and biochemical characterization of REP8839, a novel inhibitor of methionyl-tRNA synthetase. Antimicrob Agents Chemother. 2005 Oct;49 (10) :4253-62.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 1
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15156986 1 Vial
Lentiviral human ANTKMT shRNA (UAS) - Lentiviral human ANTKMT shRNA (UAS, iRFP) (25)
Ask
View Details